Capital International Ltd. CA boosted its Regeneron Pharmaceuticals holdings by 14.5% in Q4, now holding nearly $29.2 million ...

Biotechs (Regeneron and Amgen) also played a key role here. Ferguson looks for solid cash flows and strong balance sheets and likes to scoop up biotechs after their share prices decline.

This was the stock's third consecutive day of gains.

FUJIFILM has invested about $4 billion in building biopharmaceutical manufacturing sites and life sciences capabilities.

FujiFilm Diosynth plans to produce Regeneron's biologic medicines over 10 years in its Holly Springs facility, which is scheduled to begin operations this year.

Wall Street analysts expect Regeneron (REGN) to post quarterly earnings of $8.76 per share in its upcoming report, which indicates a year-over-year decline of 8.3%. Revenues are expected to be $3.25 ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

Amid such uncertain times, investors should note that a market recovery predicated on a reversal of the current themes could see the fund bounce back sharply. Together with T. Rowe Price's ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

Sources: FactSet, Dow Jones Stock Movers: Gainers, decliners and most actives market activity tables are ... Tullett Prebon Commodities & Futures: Futures prices are delayed at least 10 minutes ...

The study will kick off by testing 300,000 samples – 250,000 first and 50,000 second samples - at the Regeneron Genetics Center in the US, with funding for that stage of the project provided by ...

“To meet the growing demand and market opportunity, a pharma company must ensure it has the resources, capacity, and supply chain to grow.” To continue operations sustainably – and be in a ...